A Study to Evaluate the Effect of Camicinal on Gastroparesis Symptoms in Type 1 and 2 Diabetic Subjects With Gastroparesis
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 114 participants.
Also called NCT02210000
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 114 participants
- Sponsor
- Registry
-
NCT02210000
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT02210000. Randomized; double masking; primary purpose treatment. Start 2014-08-27 (actual); primary completion 2015-08-24 (actual). Results posted on 2017-11-01.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Evaluate the Effect of Camicinal on Gastroparesis Symptoms in Type 1 and 2 Diabetic Subjects With Gastroparesis
- Condition
- Gastroparesis
- Intervention (Drug)
- Placebo
- Intervention (Drug)
- Camicinal
- Lead sponsor
- GlaxoSmithKline
Record details
- Record id
cardio:ct-nct02210000- Content hash
30d2edca3b6e77b437477fab1dcbff010f1854613953e46c110a5f22d9837daa